Bhuiyan, P. & Rege, N. ICH Harmonised Tripartite Guideline: guideline for good clinical practice. (2001).Kohn, L. T., Corrigan, J. M. & Donaldson, M. S. (National Academy, 2000).Poudel, D. R., Acharya, P., Ghimire, S., Dhital, R. & Bharati, R. Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database. Pharmacoepidemiol. Drug Saf. 26, 635–641 (2017).Article
CAS
PubMed
Google Scholar
Karimi, S., Wang, C., Metke-Jimenez, A., Gaire, R. & Paris, C. Text and data mining techniques in adverse drug reaction detection. ACM Comput. Surv. (CSUR) 47, 1–39 (2015).Article
Google Scholar
Pierce, C. E. et al. Evaluation of Facebook and Twitter monitoring to detect safety signals for medical products: an analysis of recent FDA safety alerts. Drug Saf. 40, 317–331 (2017).Article
PubMed
PubMed Central
Google Scholar
Yom-Tov, E. & Gabrilovich, E. Postmarket drug surveillance without trial costs: discovery of adverse drug reactions through large-scale analysis of web search queries. J. Med. Internet. Res. 15, e124 (2013).Article
PubMed
PubMed Central
Google Scholar
Nguyen, D. A., Nguyen, C. H. & Mamitsuka, H. A survey on adverse drug reaction studies: data, tasks and machine learning methods. Brief. Bioinform. 22, 164–177 (2021).Article
PubMed
Google Scholar
Dey, S., Luo, H., Fokoue, A., Hu, J. & Zhang, P. Predicting adverse drug reactions through interpretable deep learning framework. BMC Bioinform. 19, 1–13 (2018).Article
Google Scholar
Ding, Y., Tang, J. & Guo, F. Identification of drug-side effect association via multiple information integration with centered kernel alignment. Neurocomputing 325, 211–224 (2019).Article
Google Scholar
Jamal, S., Goyal, S., Shanker, A. & Grover, A. Predicting neurological adverse drug reactions based on biological, chemical and phenotypic properties of drugs using machine learning models. Sci. Rep. 7, 1–12 (2017).Article
CAS
Google Scholar
Liu, M. et al. Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs. J. Am. Med. Inform. Assoc. 19, e28–e35 (2012).Article
PubMed
PubMed Central
Google Scholar
Wang, C. S. et al. Detecting potential adverse drug reactions using a deep neural network model. J. Med. Internet. Res. 21, e11016 (2019).Article
PubMed
PubMed Central
Google Scholar
Zhang, W., Liu, F., Luo, L. & Zhang, J. Predicting drug side effects by multi-label learning and ensemble learning. BMC Bioinform. 16, 1–11 (2015).Article
Google Scholar
Finkelstein, J., Chen, Q., Adams, H. & Friedman, C. Automated summarization of publications associated with adverse drug reactions from PubMed. AMIA Summits on Translational Science Proceedings 68 (2016). (2016).Lee, K. et al. In Proc. 26th international conference on world wide web. 705–714.Munkhdalai, T., Liu, F. & Yu, H. Clinical relation extraction toward drug safety surveillance using electronic health record narratives: classical learning versus deep learning. JMIR Public. Health Surveillance 4, e29 (2018).Article
PubMed
PubMed Central
Google Scholar
Yahya, A. A., Asiri, Y. & Alyami, I. In 2020 21st International Arab Conference on Information Technology (ACIT). 1–6 (IEEE).Muñoz, E., Nováček, V. & Vandenbussche, P. Y. In AMIA Annual Symposium Proceedings. 924 (American Medical Informatics Association).Rahmani, H., Weiss, G., Méndez-Lucio, O., Bender, A. & ARWAR. A network approach for predicting adverse drug reactions. Comput. Biol. Med. 68, 101–108 (2016).Article
CAS
PubMed
Google Scholar
Alberti, P. & Cavaletti, G. Management of side effects in the personalized medicine era: chemotherapy-induced peripheral neuropathy. Pharmacogenomics Drug Discovery Dev., 301–322 (2014).Lee, H., Song, S., Oh, Y. K., Kang, W. & Kim, E. Is gender still a predisposing factor in contrast-media associated adverse drug reactions? A systematic review and meta-analysis of randomized trials and observational studies. Eur. J. Radiol. 89, 81–89 (2017).Article
PubMed
Google Scholar
Watson, S., Caster, O., Rochon, P. A. & den Ruijter, H. Reported adverse drug reactions in women and men: aggregated evidence from globally collected individual case reports during half a century. EClinicalMedicine 17, 100188 (2019).Article
PubMed
PubMed Central
Google Scholar
Zekarias, A., Watson, S., Vidlin, S. H. & Grundmark, B. Sex differences in reported adverse drug reactions to COVID-19 drugs in a global database of individual case safety reports. Drug Saf. 43, 1309–1314 (2020).Article
CAS
PubMed
PubMed Central
Google Scholar
Hunt, C. M., Yuen, N. A., Stirnadel-Farrant, H. A. & Suzuki, A. Age-related differences in reporting of drug-associated liver injury: data-mining of WHO Safety Report Database. Regul. Toxicol. Pharmacol. 70, 519–526 (2014).Article
CAS
PubMed
Google Scholar
Alomar, M. J. Factors affecting the development of adverse drug reactions. Saudi Pharm. J. 22, 83–94 (2014).Article
PubMed
Google Scholar
Wu, L. et al. Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA. BMC Bioinform. 20, 129–139 (2019).Article
Google Scholar
Breiman, L. Random forests. Mach. Learn. 45, 5–32 (2001).Article
Google Scholar
Fawcett, T. An introduction to ROC analysis. Pattern Recognit. Lett. 27, 861–874 (2006).Article
ADS
Google Scholar
Harpaz, R. et al. Text mining for adverse drug events: the promise, challenges, and state of the art. Drug Saf. 37, 777–790 (2014).Article
CAS
PubMed
PubMed Central
Google Scholar
Wishart, D. S. et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074–D1082 (2018).Article
CAS
PubMed
Google Scholar
Kim, S. et al. PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res. 49, D1388–D1395 (2021).Article
CAS
PubMed
Google Scholar
Chen, X. et al. Network characteristic analysis of ADR-related proteins and identification of ADR-ADR associations. Sci. Rep. 3, 1–7 (2013).CAS
Google Scholar
Ji, Z. L. et al. Drug adverse reaction target database (DART). Drug Saf. 26, 685–690 (2003).Article
CAS
PubMed
Google Scholar
Whitebread, S., Hamon, J., Bojanic, D. & Urban, L. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development. Drug Discovery Today 10, 1421–1433 (2005).Article
CAS
PubMed
Google Scholar
Taylor, J. B. Comprehensive Medicinal Chemistry II (Elsevier, 2007).Knox, C. et al. DrugBank 3.0: a comprehensive resource for ‘omics’ research on drugs. Nucleic Acids Res. 39, D1035–D1041 (2010).Article
PubMed
PubMed Central
Google Scholar
Liu, C. X. et al. Herb-drug interactions involving drug metabolizing enzymes and transporters. Curr. Drug Metab. 12, 835–849 (2011).Article
CAS
PubMed
Google Scholar
Lutz, H., Hu, S., Dinh, P. U. & Cheng, K. Cells and cell derivatives as drug carriers for targeted delivery. Med. Drug Discovery 3, 100014 (2019).Article
Google Scholar
Dong, J. et al. ChemDes: an integrated web-based platform for molecular descriptor and fingerprint computation. J. Cheminform. 7, 1–10 (2015).Article
Google Scholar
Kim, S. et al. PubChem structure–activity relationship (SAR) clusters. J. Cheminform. 7, 1–22 (2015).Article
ADS
Google Scholar
Yu, Y. et al. Detecting and Filtering Immune-Related Adverse Events Signal Based on Text Mining and Observational Health Data Sciences and Informatics Common Data Model: Framework Development Study. JMIR Med. Inf. 8, e17353 (2020).Banda, J. M. et al. A curated and standardized adverse drug event resource to accelerate drug safety research. Sci. Data 3, 1–11 (2016).Article
ADS
Google Scholar
Dasu, T. & Johnson, T. Exploratory data Mining and data Cleaning. Vol. 479 (Wiley, 2003).Khaleel, M. A., Khan, A. H., Ghadzi, S. M. S., Adnan, A. S. & Abdallah, Q. M. In Healthcare 420 (MDPI).Cepeda, M. S. et al. Side effects of opioids during short-term administration: Effect of age, gender, and race. Clin. Pharmacol. Ther. 74, 102–112 (2003).Article
CAS
PubMed
Google Scholar
Rich, M. W., McSherry, F., Williford, W. O., Yusuf, S. & Group, D. I. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study. J. Am. Coll. Cardiol. 38, 806–813 (2001).Article
CAS
PubMed
Google Scholar
Kuhn, M., Letunic, I., Jensen, L. J. & Bork, P. The SIDER database of drugs and side effects. Nucleic Acids Res. 44, D1075–D1079 (2016).Article
CAS
PubMed
Google Scholar
MacCallum, R. C., Widaman, K. F., Zhang, S. & Hong, S. Sample size in factor analysis. Psychol. Methods 4, 84 (1999).Article
Google Scholar
Hu, B., Wang, H., Wang, L. & Yuan, W. Adverse drug reaction predictions using stacking deep heterogeneous information network embedding approach. Molecules 23, 3193 (2018).Article
PubMed
PubMed Central
Google Scholar
Fattinger, K. et al. Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine. Br. J. Clin. Pharmacol. 49, 158–167 (2000).Article
CAS
PubMed
PubMed Central
Google Scholar
Zopf, Y. et al. Women encounter ADRs more often than do men. Eur. J. Clin. Pharmacol. 64, 999–1004 (2008).Article
CAS
PubMed
Google Scholar
Rodenburg, E. M., Stricker, B. H. C. & Visser, L. E. Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands. Br. J. Clin. Pharmacol. 71, 95–104 (2011).Article
PubMed
PubMed Central
Google Scholar
Nicolson, T. J., Mellor, H. R. & Roberts, R. R. gender differences in drug toxicity. Trends Pharmacol. Sci. 31, 108–114 (2010).Article
CAS
PubMed
Google Scholar
Yu, Y. M. et al. Patterns of adverse drug reactions in different age groups: analysis of spontaneous reports by community pharmacists. PloS One 10, e0132916 (2015).Article
PubMed
PubMed Central
Google Scholar
de Araújo Lobo, M. G. A., Pinheiro, S. M. B., Castro, J. G. D., Momenté, V. G. & Pranchevicius, M. C. S. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil. BMC Pharmacol. Toxicol. 14, 1–7 (2013).
Google Scholar
Arnott, J. A., Kumar, R. & Planey, S. L. Lipophilicity indices for drug development. J. Appl. Biopharm. Pharmacokinet. 1, 31–36 (2013).
Google Scholar
Arnott, J. A. & Planey, S. L. The influence of lipophilicity in drug discovery and design. Expert Opin. Drug Discov. 7, 863–875 (2012).Article
CAS
PubMed
Google Scholar
Leeson, P. D. & Springthorpe, B. The influence of drug-like concepts on decision-making in medicinal chemistry. Nat. Rev. Drug Discovery 6, 881–890 (2007).Article
CAS
PubMed
Google Scholar
Chen, M., Borlak, J. & Tong, W. High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury. Hepatology 58, 388–396 (2013).Article
CAS
PubMed
Google Scholar
Valko, K., Chiarparin, E., Nunhuck, S. & Montanari, D. In vitro measurement of drug efficiency index to aid early lead optimization. J. Pharm. Sci. 101, 4155–4169 (2012).Article
CAS
PubMed
Google Scholar
Zhang, J., Qian, J., Tong, J., Zhang, D. & Hu, C. Toxic effects of cephalosporins with specific functional groups as indicated by zebrafish embryo toxicity testing. Chem. Res. Toxicol. 26, 1168–1181 (2013).Article
CAS
PubMed
Google Scholar
Clark, D. E. What has polar surface area ever done for drug discovery? Future Med. Chem. 3, 469–484 (2011).Article
ADS
CAS
PubMed
Google Scholar
Prasanna, S. & Doerksen, R. Topological polar surface area: a useful descriptor in 2D-QSAR. Curr. Med. Chem. 16, 21–41 (2009).Article
CAS
PubMed
PubMed Central
Google Scholar
Hughes, J. D. et al. Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorg. Med. Chem. Lett. 18, 4872–4875 (2008).Article
CAS
PubMed
Google Scholar
Chagas, C. M., Moss, S. & Alisaraie, L. Drug metabolites and their effects on the development of adverse reactions: revisiting Lipinski’s rule of five. Int. J. Pharm. 549, 133–149 (2018).Article
CAS
PubMed
Google Scholar
Leach, A. R. & Hann, M. M. Molecular complexity and fragment-based drug discovery: ten years on. Curr. Opin. Chem. Biol. 15, 489–496 (2011).Article
CAS
PubMed
Google Scholar
Gleeson, M. P. Generation of a set of simple, interpretable ADMET rules of thumb. J. Med. Chem. 51, 817–834 (2008).Article
CAS
PubMed
Google Scholar
Sharma, A., Kumar, N., Kuppermann, B. D., Bandello, F. & Loewenstein, A. Biotherapeutics and immunogenicity: ophthalmic perspective. Eye 33, 1359–1361 (2019).Article
PubMed
PubMed Central
Google Scholar
Lovering, F., Bikker, J. & Humblet, C. Escape from flatland: increasing saturation as an approach to improving clinical success. J. Med. Chem. 52, 6752–6756 (2009).Article
CAS
PubMed
Google Scholar
Mealey, K. L. Adverse drug reactions in veterinary patients associated with drug transporters. Veterinary Clin. Small Anim. Pract. 43, 1067–1078 (2013).Article
Google Scholar
Takenaka, S., Itoh, T. & Fujiwara, R. Expression pattern of human ATP-binding cassette transporters in skin. Pharmacol. Res. Perspect. 1 (2013).Yamasaki, K., Chuang, V. T. G., Maruyama, T. & Otagiri, M. Albumin–drug interaction and its clinical implication. Biochim. et Biophys. Acta (BBA)-General Subj. 1830, 5435–5443 (2013).Article
CAS
Google Scholar
Lavan, A. H. & Gallagher, P. Predicting risk of adverse drug reactions in older adults. Therapeutic Adv. drug Saf. 7, 11–22 (2016).Article
Google Scholar